Clinical Trial Update: Diagnostic Outcome Trial in Heart Failure (DOT-HF Trial) [Phase 4]

View source ↗

Summary

Phase 4 diagnostic outcomes trial for heart failure (DOT-HF) sponsored by Medtronic Cardiac Rhythm and Heart Failure. The study was terminated and results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Heart Failure | Phase 4 | Status: TERMINATED | Results posted: 2019-02-19